Is Repligen Corporation overvalued?

Repligen Corporation (RGEN) — key valuation metrics and fundamentals.

No verdict

Price

$139.21

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$7.78B

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares RGEN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.

Related stocks